Not one attempt to extract more from them, or at least no public rebuffal. Now they say it's business as usual. Could have defended the offer and done that all along.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025